2020 Form 10-K Financial Statement

#000106299320003916 Filed on August 13, 2020

View on sec.gov

Income Statement

Concept 2020 2019 Q1 2019
Revenue $41.14M $7.990M $32.20M
YoY Change 27.76% 33.84% 62.54%
Cost Of Revenue $24.30M $4.950M $19.25M
YoY Change 26.23% 27.25% 64.67%
Gross Profit $16.84M $3.040M $12.95M
YoY Change 30.04% 46.15% 59.29%
Gross Profit Margin 40.93% 38.05% 40.22%
Selling, General & Admin $30.21M $5.490M $20.43M
YoY Change 47.87% 83.61% 49.78%
% of Gross Profit 179.39% 180.59% 157.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.010M $250.0K $580.0K
YoY Change 74.14% 92.31% 38.1%
% of Gross Profit 6.0% 8.22% 4.48%
Operating Expenses $31.22M $5.730M $21.01M
YoY Change 48.6% 83.65% 49.54%
Operating Profit -$14.38M -$2.690M -$8.060M
YoY Change 78.41% 158.65% 36.15%
Interest Expense -$450.0K -$140.0K -$550.0K
YoY Change -18.18% 27.27% -27.63%
% of Operating Profit
Other Income/Expense, Net -$448.8K -$554.2K
YoY Change -19.03%
Pretax Income -$14.83M -$2.840M -$8.620M
YoY Change 72.04% 146.96% 28.85%
Income Tax
% Of Pretax Income
Net Earnings -$14.83M -$2.840M -$8.620M
YoY Change 72.04% 146.96% 28.85%
Net Earnings / Revenue -36.05% -35.54% -26.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$344.7K -$80.16K -$270.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 2019 Q1 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.560M $11.03M $11.03M
YoY Change -58.66% 1014.14% 1014.14%
Cash & Equivalents $4.560M $11.03M $11.03M
Short-Term Investments
Other Short-Term Assets $1.790M $380.0K $380.0K
YoY Change 371.05% 26.67% 26.67%
Inventory $2.920M $2.058M $2.060M
Prepaid Expenses
Receivables $4.920M $3.068M $3.070M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.18M $16.54M $16.54M
YoY Change -14.27% 238.19% 238.24%
LONG-TERM ASSETS
Property, Plant & Equipment $1.420M $1.950M $1.950M
YoY Change -27.18% 66.67% 66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.430M $1.945M $1.940M
YoY Change -26.29% 66.26% 65.81%
TOTAL ASSETS
Total Short-Term Assets $14.18M $16.54M $16.54M
Total Long-Term Assets $1.430M $1.945M $1.940M
Total Assets $15.61M $18.48M $18.48M
YoY Change -15.53% 204.99% 204.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.410M $2.899M $2.900M
YoY Change 86.55% 41.41% 41.46%
Accrued Expenses $1.290M $1.095M $1.100M
YoY Change 17.27% 33.59% 34.15%
Deferred Revenue
YoY Change
Short-Term Debt $7.290M $3.130M $3.130M
YoY Change 132.91% 15.07% 15.07%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.98M $7.126M $7.130M
YoY Change 96.07% 27.24% 27.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.98M $7.126M $7.130M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $13.98M $7.126M $7.130M
YoY Change 96.07% 27.24% 27.32%
SHAREHOLDERS EQUITY
Retained Earnings -$38.69M
YoY Change
Common Stock $39.57K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.620M $11.36M $11.36M
YoY Change
Total Liabilities & Shareholders Equity $15.61M $18.48M $18.48M
YoY Change -15.53% 204.99% 204.95%

Cashflow Statement

Concept 2020 2019 Q1 2019
OPERATING ACTIVITIES
Net Income -$14.83M -$2.840M -$8.620M
YoY Change 72.04% 146.96% 28.85%
Depreciation, Depletion And Amortization $1.010M $250.0K $580.0K
YoY Change 74.14% 92.31% 38.1%
Cash From Operating Activities -$13.64M -$3.270M -$8.130M
YoY Change 67.77% 138.69% 209.13%
INVESTING ACTIVITIES
Capital Expenditures -$490.0K -$190.0K -$1.360M
YoY Change -63.97% 216.67% 325.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$490.0K -$190.0K -$1.360M
YoY Change -63.97% 216.67% 325.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.660M 11.40M 19.53M
YoY Change -60.78% 475.76% 486.49%
NET CHANGE
Cash From Operating Activities -13.64M -3.270M -8.130M
Cash From Investing Activities -490.0K -190.0K -1.360M
Cash From Financing Activities 7.660M 11.40M 19.53M
Net Change In Cash -6.470M 7.940M 10.04M
YoY Change -164.44% 1343.64% 2542.11%
FREE CASH FLOW
Cash From Operating Activities -$13.64M -$3.270M -$8.130M
Capital Expenditures -$490.0K -$190.0K -$1.360M
Free Cash Flow -$13.15M -$3.080M -$6.770M
YoY Change 94.24% 135.11% 193.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019Q3 dei Entity Public Float
EntityPublicFloat
63626402.49 USD
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64325115 shares
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4561682 USD
CY2019Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
11032451 USD
CY2020Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1422581 USD
CY2019Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1945265 USD
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
29000 shares
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
3400 USD
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
5300 USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45585592 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39573512 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45585592 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39573512 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
45585 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
39573 USD
CY2020Q1 wter Stock Payable
StockPayable
1000000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
460241 USD
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
288 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-448758 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-554194 USD
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4600000 shares
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17238429 USD
CY2019 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
1882348 USD
CY2019 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
393460 USD
CY2020 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
11996 USD
CY2020 wter Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
185510 USD
CY2019 wter Proceeds From Revolving Financing
ProceedsFromRevolvingFinancing
539264 USD
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
131583 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6470769 USD
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10043546 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 wter Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
165699 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
374500 USD
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-decoration:underline">Reclassification</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Certain accounts in the prior period were reclassified to conform to the current period financial statements presentation.</span></span></span></span></p></div>
CY2020 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
5899998 USD
CY2020 wter Expected Warrant Exercises
ExpectedWarrantExercises
258899 USD
CY2020 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The principal amount of the Revolving Facility outstanding bears interest at a rate per annum equal to (i) a fluctuating interest rate per annum equal at all times to the rate of interest announced, from time to time, within Wells Fargo Bank at its principal office in San Francisco as its "prime rate," plus (ii) 3.25%, payable monthly in arrears.&#160; The interest rate as of March 31, 2020 was 7.0%
CY2020Q1 wter Temporary Over Advance
TemporaryOverAdvance
400000 USD
CY2019Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
10450900 USD
CY2020Q1 wter Accrued Amount Under Agreement
AccruedAmountUnderAgreement
81117 USD
CY2019Q1 wter Accrued Amount Under Agreement
AccruedAmountUnderAgreement
84583 USD
CY2020 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
247167 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2019 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
2092052 shares
CY2020 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
3974000 shares
CY2018 wter Proceeds From Warrants Exercised
ProceedsFromWarrantsExercised
1950000 USD
CY2018Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4030059 shares
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6188222 shares
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2086489 shares
CY2018Q1 wter Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.79
CY2019Q1 wter Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
1.16
CY2020Q1 wter Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
1.80
CY2019 wter Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
4252541 shares
CY2020 wter Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2019 wter Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
1.40
CY2020 wter Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.90
CY2020 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.63
CY2019 wter Class Of Warrant Or Right Forfeitures And Expirations In Period
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod
2326 shares
CY2020 wter Class Of Warrant Or Right Forfeitures And Expirations In Period
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod
127733 shares
CY2019 wter Class Of Warrant Or Right Forfeitures And Expirations In Period Weighted Average Exercise Price
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
27.50
CY2020 wter Class Of Warrant Or Right Forfeitures And Expirations In Period Weighted Average Exercise Price
ClassOfWarrantOrRightForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.78
CY2020 wter Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
2086489 shares
CY2020Q1 wter Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
1.80
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8680000 USD
CY2019Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5410000 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8680000 USD
CY2019Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5410000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2019Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34800000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 wter Limitation Of Tax Deduction For Interest Expense
LimitationOfTaxDeductionForInterestExpense
0.30 pure
CY2020 wter Percentage Of Limitation Of Tax Deduction For Net Operating Losses
PercentageOfLimitationOfTaxDeductionForNetOperatingLosses
0.80 pure
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3270000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2100 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2100 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020 wter Increased Lease And Rent Expense Per Month
IncreasedLeaseAndRentExpensePerMonth
7891 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3938 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
93717 USD
CY2020Q1 wter Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
0 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M29D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070 pure

Files In Submission

Name View Source Status
0001062993-20-003916-index-headers.html Edgar Link pending
0001062993-20-003916-index.html Edgar Link pending
0001062993-20-003916.txt Edgar Link pending
0001062993-20-003916-xbrl.zip Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit23-1xu001.jpg Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wter-20200331.xml Edgar Link completed
wter-20200331.xsd Edgar Link pending
wter-20200331_cal.xml Edgar Link unprocessable
wter-20200331_def.xml Edgar Link unprocessable
wter-20200331_lab.xml Edgar Link unprocessable
wter-20200331_pre.xml Edgar Link unprocessable